More Island Pharmaceuticals Ltd news
Island Pharmaceuticals LtdASX: ILA

Galidesivir GMP manufacturing commences

Oct 1, 2026 at 8:01 PM EDT · Issued by Island Pharmaceuticals Ltd

Filed with ASX · Oct 1, 2026 at 8:01 PM EDT · 3 pages · English

On 6ix: 6ix.com/news/galidesivir-gmp-manufacturing-commences

Island Pharmaceuticals Ltd on 6ix

Earlier from Island Pharmaceuticals

  • Pivotal Marburg data secured for Galidesivir FDA pathwayAug 30
  • Island boosts Galidesivir supply as Ebola surgesAug 20
  • Texas Biomed SOW accelerates pivotal FDA pathwayJul 12
  • Investor Presentation - Ebola Clinical ProgramJul 7
  • Galidesivir approved for treatment use in in Ebola epidemicJul 6

Later from Island Pharmaceuticals

  • USAMRIID Marburg study advances towards dosingOct 18
  • Quarterly Appendix 4C and Activities ReportOct 25
All Island Pharmaceuticals news releases↗

Follow Island Pharmaceuticals into a list and get an email when it puts out news.

Follow Island Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer